These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22222157)

  • 1. Structure-activity relationships for naturally occurring coumarins as β-secretase inhibitor.
    Marumoto S; Miyazawa M
    Bioorg Med Chem; 2012 Jan; 20(2):784-8. PubMed ID: 22222157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds.
    Piazzi L; Cavalli A; Colizzi F; Belluti F; Bartolini M; Mancini F; Recanatini M; Andrisano V; Rampa A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):423-6. PubMed ID: 17998161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided design and synthesis of P1' position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors.
    Tagad HD; Hamada Y; Nguyen JT; Hidaka K; Hamada T; Sohma Y; Kimura T; Kiso Y
    Bioorg Med Chem; 2011 Sep; 19(17):5238-46. PubMed ID: 21803585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Secretase (BACE-1) inhibitory effect of biflavonoids.
    Sasaki H; Miki K; Kinoshita K; Koyama K; Juliawaty LD; Achmad SA; Hakim EH; Kaneda M; Takahashi K
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4558-60. PubMed ID: 20598535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-secretase inhibitory effects of furanocoumarins from the root of Angelica dahurica.
    Marumoto S; Miyazawa M
    Phytother Res; 2010 Apr; 24(4):510-3. PubMed ID: 20041416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of isoimperatorin and imperatorin by Glomerella cingulata and beta-secretase inhibitory activity.
    Marumoto S; Miyazawa M
    Bioorg Med Chem; 2010 Jan; 18(1):455-9. PubMed ID: 19939683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors.
    Malamas MS; Erdei J; Gunawan I; Turner J; Hu Y; Wagner E; Fan K; Chopra R; Olland A; Bard J; Jacobsen S; Magolda RL; Pangalos M; Robichaud AJ
    J Med Chem; 2010 Feb; 53(3):1146-58. PubMed ID: 19968289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships for bergenin analogues as β-secretase (BACE1) inhibitors.
    Kashima Y; Miyazawa M
    J Oleo Sci; 2013; 62(6):391-401. PubMed ID: 23728330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BACE1 inhibitory activities of enantiomerically pure, variously substituted N-(3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropyl) arylsulfonamides.
    Bertini S; Ghilardi E; Asso V; Granchi C; Minutolo F; Pineschi M; Di Bussolo V; Bortolato A; Moro S; Saba A; Macchia M
    Bioorg Med Chem; 2010 Nov; 18(22):7991-6. PubMed ID: 20934348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease.
    Silvestri R
    Med Res Rev; 2009 Mar; 29(2):295-338. PubMed ID: 18651582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
    Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
    J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design and synthesis of potent dibenzazepine motifs as beta-secretase inhibitors.
    Al-Tel TH; Al-Qawasmeh RA; Schmidt MF; Al-Aboudi A; Rao SN; Sabri SS; Voelter W
    J Med Chem; 2009 Oct; 52(20):6484-8. PubMed ID: 19788239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of potent inhibitors of human beta-secretase. Part 1.
    Freskos JN; Fobian YM; Benson TE; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Moon JB; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G
    Bioorg Med Chem Lett; 2007 Jan; 17(1):73-7. PubMed ID: 17046251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acylguanidines as small-molecule beta-secretase inhibitors.
    Cole DC; Manas ES; Stock JR; Condon JS; Jennings LD; Aulabaugh A; Chopra R; Cowling R; Ellingboe JW; Fan KY; Harrison BL; Hu Y; Jacobsen S; Jin G; Lin L; Lovering FE; Malamas MS; Stahl ML; Strand J; Sukhdeo MN; Svenson K; Turner MJ; Wagner E; Wu J; Zhou P; Bard J
    J Med Chem; 2006 Oct; 49(21):6158-61. PubMed ID: 17034121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human beta-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays.
    Garino C; Tomita T; Pietrancosta N; Laras Y; Rosas R; Herbette G; Maigret B; Quéléver G; Iwatsubo T; Kraus JL
    J Med Chem; 2006 Jul; 49(14):4275-85. PubMed ID: 16821787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as γ-secretase inhibitors.
    Parker MF; Barten DM; Bergstrom CP; Bronson JJ; Corsa JA; Dee MF; Gai Y; Guss VL; Higgins MA; Keavy DJ; Loo A; Mate RA; Marcin LR; McElhone KE; Polson CT; Roberts SB; Macor JE
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6828-31. PubMed ID: 23046960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel BACE1 inhibitors with a non-acidic heterocycle at the P1' position.
    Suzuki K; Hamada Y; Nguyen JT; Kiso Y
    Bioorg Med Chem; 2013 Nov; 21(21):6665-73. PubMed ID: 23993670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of gamma-secretase and BACE1 inhibition on brain Abeta levels in vitro and in vivo.
    Elvang AB; Volbracht C; Pedersen LØ; Jensen KG; Karlsson JJ; Larsen SA; Mørk A; Stensbøl TB; Bastlund JF
    J Neurochem; 2009 Sep; 110(5):1377-87. PubMed ID: 19519664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of gamma-secretase by the CK1 inhibitor IC261 does not depend on CK1delta.
    Höttecke N; Liebeck M; Baumann K; Schubenel R; Winkler E; Steiner H; Schmidt B
    Bioorg Med Chem Lett; 2010 May; 20(9):2958-63. PubMed ID: 20350806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple structure-based approach for predicting the activity of inhibitors of beta-secretase (BACE1) associated with Alzheimer's disease.
    Nastase AF; Boyd DB
    J Chem Inf Model; 2012 Dec; 52(12):3302-7. PubMed ID: 23198745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.